Top Selling next-generation probiotic

Contains 53 different strains, including the #1 digestive probiotic strain in Europe

4.7 Based on 769 Reviews
Kijimea K53

Kijimea K53

Kijimea K53 contains a unique composition of 53 natural bacterial strains – selected to promote a healthy gut microbiome in its richness and diversity.*

  • Unique and comprehensive blend of 53 diverse strains: holistic approach to the Gut Microbiome
  • Including L. rhamnosus GG and B. animalis ssp. lactis MW21¹ - two of the world’s most clinically studied strains, with 140+ publications
  • Engineered for stability, with the double-wall aluminum blister
  • Among the most-sold, scientifically validated probiotics in Europe – with more than 2.7 million happy customers

As featured in

Shop with confidence

4.7
Based on 769 Reviews

"Since I've been taking Kijimea, I've been regulated like a Swiss watch. I have already recommended it to others."

Kornelia

Verified Buyer

Kijimea K53 is recommended by doctors, pharmacists and customers

91%

of our customers would recommend Kijimea K53 to a friend².

90%

of our customers would buy Kijimea K53 again².

Very easy to use

Suggested use of Kijimea K53:

Take one Kijimea K53 capsule daily – preferably with a sufficient amount of water.

Kijimea K53 capsules can also be easily opened and the content consumed with a small amount of liquid, of for example yogurt, milk or your breakfast cereal.

Validated in no less than 110 gold-standard trials

Randomized controlled trials are the gold standard in scientific research. Our key strains have been validated in no less than 110 gold-standard trials.

  • 15 x Increase in beneficial bacteria³
  • +2.3 Improved Intestinal regularity⁴

    ³In a 30-day clinical trial.
    ⁴Compared to placebo. In a 12-week clinical trial.

Here’s how Kijimea K53 compares to similar products on the market

# of strains

Kijimea
53

53

Other
20 or less strains

20 or less strains

Moisture proof packaging

Kijimea
Moisture-proof alu-alu single packaging of each capsule

Moisture-proof alu-alu single packaging of each capsule

Other
Rare

Rare

Vitamin B₆ 

Kijimea
Vitamin B₆ for protein metabolism*

Vitamin B₆ for protein metabolism*

Other
Rare

Rare

Zinc

Kijimea
Zinc for immune system

Zinc for immune system

Other
Rare

Rare

Save up to 40% on Kijimea K53 now

Returns: 30-day money-back guarantee

One-Time purchase

3-month supply

3-month supply
$177$149

One time purchase.

1-month supply

1-month supply
$59

One time purchase.

Order now, pay later with:

Apple Pay, Google Pay, PayPal
Free shipping on subscriptions within the USA.
GMP-certified manufacturers: carefully manufactured in GMP (Good Manufacturing Practice) facilities.

Questions? We are happy to help

What can I expect while taking Kijimea K53?

The intestinal microbiome hosts trillions of unique bacteria and plays a major role in human well-being through its intimate interaction with the body.
Kijimea K53 is a probiotic supplement which combines 53 carefully selected probiotic strains to support a healthy gut microbiome.*

How do I take Kijimea K53?

Take one capsule daily with a sufficient amount of water. Daily use for at least 12 weeks is recommended.

Do not exceed recommended daily dose. Keep out of reach of children.

Why should I take Kijimea K53 daily?

Consistent use can help to support the benefits of the clinically studied strains*.
We recommend a daily use for at least 12 weeks. When starting, your gut microbiome may take some time to adjust to the daily introduction of probiotics.

Do I need to refrigerate Kijimea K53?

No refrigeration is necessary.

Is Kijimea K53 safe to take while I'm pregnant or breastfeeding?

As with any dietary supplement or new health protocol, we recommend consulting a healthcare professional before you start consuming Kijimea K53 if you are pregnant or breastfeeding or trying to become pregnant, especially if taken in combination with other supplements containing zinc or vitamin B₆.

What pack sizes of Kijimea K53 are available?

Kijimea K53 is available in the following pack size: 30 capsules of 0.28 g each = 8.4 g

Is Kijimea K53 suitable for children?

Kijimea K53 is suitable for adults and children over the age of 14.
As with any dietary supplement or new health protocol for children under 18 years, we recommend consulting a healthcare professional before you start consuming Kijimea K53.

Is Kijimea K53 well tolerated?

There are no known side effects or interactions associated with the consumption of Kijimea K53. Consult your healthcare professional if you are taking, have recently taken or are planning to take any medicines together with Kijimea K53.

Kijimea K53 contains Milk.

Who is the distributor of Kijimea K53?

The product is distributed by Kijimea Inc. (120 Wall Street, New York, NY 10005)

How can I contact you?

Connect with our expert team: Our customer support team is ready to assist with any questions about our research, benefits or product details. Call us: +1-833-368-8468 Mon-Fri, 7-10 AM EST

References
Agamennone, V., Krul, C. A. M., Rijkers, G., & Kort, R. (2018). A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands. BMC gastroenterology, 18(1), 103. https://doi.org/10.1186/s12876-018-0831-x. PMID: 30078376; PMCID: PMC6091175.
Dronkers TMG, Ouwehand AC, Rijkers GT. Global analysis of clinical trials with probiotics. Heliyon. 2020 Jul 7;6(7):e04467. doi: 10.1016/.heliyon.2020.e04467. PMID: 32715136; PMCID: PMC7371762.
Jungersen M, Wind A, Johansen E, Christensen JE, Stuer-Lauridsen B, Eskesen D. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®). Microorganisms. 2014 Mar 28;2(2):92-110. doi:10.3390/microorganisms2020092. PMID: 27682233; PMCID: PMC5029483.
Li, Y. T., Xu, H., Ye, J. Z., Wu, W. R., Shi, D., Fang, D. Q., Liu, Y., & Li, L. J. (2019). Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis. World journal of gastroenterology, 25(33), 4999–5016. https://doi.org/10.3748/wjg.v25.i33.4999. PMID: 31543689; PMCID: PMC6737314.
McFarland L. V. (2006). Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. The American journal of gastroenterology, 101(4), 812-822. https://doi.org/10.1111/j.1572-0241.2006.00465.x PMID: 16635227.
Szajewska, H., Canani, R. B., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Orel, R., Shamir, R., Vandenplas, Y., van Goudoever, J. B., Weizman, Z., & ESPGHAN Working Group for Probiotics Prebiotics (2016). Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children. Journal of pediatric gastroenterology and nutrition, 62(3), 495–506. https://doi.org/10.1097/MPG.0000000000001081. PMID: 25756877.
Szajewska, H., & Kołodziej, M. (2015). Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Alimentary pharmacology & therapeutics, 42(10), 1149–1157. https://doi.org/10.1111/apt.13404. PMID: 26365389.
Vandenplas, Y., Huys, G., & Daube, G. (2015). Probiotics: an update. Jornal de pediatria, 91(1), 6–21. https://doi.org/10.1016/j.jped.2014.08.005. PMID: 25458874.
The reviews and user experiences presented on this website are based on voluntary feedback from real customers. They reflect individual experiences and may not be representative of typical results.
¹ In the clinical studies referred as B. animalis ssp. Lactis BB-12®
²Customer survey on the product K53 (Europe), conducted between October 31, 2025 and December 12, 2025 in Europe. Self-assessment by 522 customers regarding recommendation, satisfaction, tolerability, expectations, and repurchase intentions. Participation was voluntary, anonymous, and without financial incentives.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.